How might stricter norms for tracking high-risk solvents impact the pharmaceutical supply chain and public health in India?
The DCGI has introduced stricter tracking norms for high-risk solvents. I want to analyze the possible effects of this policy on the safety, efficiency, and integrity of the pharmaceutical supply chain.